As of 4:41:04 PM GMT+1. Market Open.
Loading Chart for R9U2.BE
DELL
- Previous Close
8.13 - Open
7.82 - Bid 7.78 x --
- Ask 8.10 x --
- Day's Range
7.80 - 7.94 - 52 Week Range
7.22 - 14.25 - Volume
0 - Avg. Volume
1 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Feb 26, 2025 - Mar 3, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: R9U2.BE
View MorePerformance Overview: R9U2.BE
Trailing total returns as of 1/7/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
R9U2.BE
6.89%
S&P/TSX Composite index
1.80%
1-Year Return
R9U2.BE
27.09%
S&P/TSX Composite index
19.71%
3-Year Return
R9U2.BE
56.31%
S&P/TSX Composite index
18.94%
5-Year Return
R9U2.BE
5.66%
S&P/TSX Composite index
46.53%
Compare To: R9U2.BE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
7.83
-3.69%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
5.25
-2.78%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
5.20
-5.45%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
5.10
-5.56%
Mkt Cap EUR 426.304M
Industry Drug Manufacturers—Specialty & Generic
5.03
-3.59%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
1.3100
+0.77%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
5.55
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.3460
-0.57%
Mkt Cap EUR 124.586M
Industry Drug Manufacturers—Specialty & Generic
5.31
-2.30%
Mkt Cap EUR 1.023B
Industry Drug Manufacturers—Specialty & Generic
0.1796
-15.08%
Mkt Cap EUR 30.836M
Industry Drug Manufacturers—Specialty & Generic
Statistics: R9U2.BE
View MoreValuation Measures
As of 1/6/2025
Market Cap
1.85B
Enterprise Value
2.20B
Trailing P/E
31.03
Forward P/E
15.43
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.79
Price/Book (mrq)
1.12
Enterprise Value/Revenue
2.02
Enterprise Value/EBITDA
6.01
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--